Improved Mobility
While we work toward treatments that address FARS2 deficiency itself, we're equally committed to helping people affected by the disease move more easily, maintain independence, and enjoy fuller lives.
For many individuals with FARS2 deficiency, progressive muscle stiffness, weakness, and impaired coordination can make walking and everyday movement increasingly difficult.
These challenges can affect almost every aspect of life—from navigating school or work to exercising, traveling, and participating in social activities.
Although advances in gene therapy and drug development offer hope for the future, people living with FARS2 need effective mobility solutions today.
Our Approach
We're exploring how established rehabilitation methods and emerging assistive technologies can help people with FARS2 deficiency preserve mobility and independence.
Our strategy focuses on three areas:
Physical therapy and rehabilitation. Targeted stretching, strengthening, gait training, and other interventions can help manage muscle stiffness, maintain flexibility, and support safe movement.
Advanced mobility aids. Ankle-foot orthoses, walking supports, and other devices can provide stability, improve walking mechanics, and reduce the risk of falls.
Emerging movement technologies. Robotic rehabilitation systems, wearable devices, and powered exoskeletons are creating new possibilities for assisting movement in people with neurological and muscular disorders.
Our goal is to identify the approaches that offer the greatest practical benefits for individuals with FARS2 deficiency.
Why Focusing on Movement Matters
FARS2 deficiency can cause a form of hereditary spastic paraplegia, in which increasing muscle stiffness and impaired motor control make walking more challenging.
People affected by these symptoms may experience:
Muscle tightness and restricted range of motion
Toe walking and abnormal gait patterns
Difficulties with balance and coordination
Fatigue and reduced walking endurance
An increasing need for mobility assistance
Maintaining movement is important not only for physical health but also for independence, social participation, and quality of life.
Assistive technologies can sometimes compensate for lost function even when they cannot correct the underlying disease.
Exploring New Technologies
Rapid advances in robotics, sensors, and wearable technology are expanding the possibilities for helping people with mobility impairments.
Some of the technologies we're interested in exploring include:
Robotic gait-training systems that help people practice coordinated walking movements.
Powered exoskeletons that provide mechanical assistance to the legs.
Smart braces and orthotics that adapt to movement and support more efficient walking.
Wearable sensors that track gait, balance, and changes in mobility over time.
These technologies vary widely in cost, availability, and clinical evidence. Some remain experimental or may not be appropriate for particular symptoms.
Our aim is to evaluate which approaches are most relevant to FARS2 deficiency and could deliver meaningful benefits.
Building a Practical Research Agenda
Because FARS2 deficiency affects so few people, there is little research specifically examining which rehabilitation methods or assistive technologies work best for this condition.
We hope to help close that gap by:
Connecting families with clinicians and rehabilitation specialists experienced in neurological movement disorders.
Identifying promising technologies already being used for related conditions.
Exploring opportunities for individualized assessments and small pilot studies.
Sharing practical findings and resources with the FARS2 community.
Improving Lives While We Pursue a Cure
Our work on assisted movement complements our gene therapy and drug repurposing programs.
Even if future treatments can slow or stop disease progression, individuals who have already developed mobility impairments may continue to need rehabilitation and assistive support.
These approaches could become an essential part of helping patients benefit from future medical breakthroughs.
Our commitment is simple: pursue transformative treatments for tomorrow while helping people with FARS2 live more independently today.